• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尼日利亚注射吸毒者中 HIV 流行率和风险行为简介:我们是否应该警惕?

A profile on HIV prevalence and risk behaviors among injecting drug users in Nigeria: should we be alarmed?

机构信息

Population Council Nigeria, 3rd Floor, Bassan Plaza, Plot 759 Cadastral Zone AO, Central Business District, Abuja, Nigeria.

出版信息

Drug Alcohol Depend. 2013 Jan 1;127(1-3):65-71. doi: 10.1016/j.drugalcdep.2012.06.013. Epub 2012 Jul 8.

DOI:10.1016/j.drugalcdep.2012.06.013
PMID:22776443
Abstract

OBJECTIVE

Injecting drug use is now recognized as a significant risk factor for HIV in sub-Saharan Africa. We evaluated prevalence and correlates of HIV among injecting drug users (IDUs) in Nigeria.

METHODS

A cross sectional design using respondent driven sampling was conducted in six states in 2010. Weighted HIV prevalence and injecting risk behaviors calculated using RDS analytic tool. Logistic regression was used to determine correlates of HIV infection, stratified by state.

RESULTS

Total numbers of IDUs ranged from 197 in Lagos to 273 in Cross River and Oyo states. HIV prevalence was highest in Federal Capital Territory (FCT) at 9.3%, Kaduna 5.8%, Oyo 5.1%, Kano 4.9%, CR 3.3% and Lagos 3.0%. Although >90% of participants were male, females had higher HIV prevalence in all states surveyed except FCT (range: 7.4% in CR to 37.7% in Kano). Logistic regression showed that females were significantly more likely to be HIV positive in Kano [OR=33.2, 95% CI: 6.8-160.4], Oyo [AOR=15.9, 95% CI: 3.69-68.51], Lagos [OR=15.5, 95% CI: 2.41-99.5] and Kaduna states [AOR=19.6, 95% CI: 4.4-87.6]. For injecting risk behavior, only receptive sharing was associated with HIV [AOR=7.6, 95% CI: 1.2-48.7] and [AOR=0.2, 95% CI: 0.04-0.92] in Oyo and Kaduna states respectively.

CONCLUSIONS

Considerable heterogeneity in the prevalence of HIV and associated risk behaviors exist among IDUs across Nigeria. Females had higher HIV prevalence among IDUs in five of six states, suggesting a need for targeted interventions for this hidden subgroup. Further research is needed to understand HIV transmission dynamics of IDUs in Nigeria. Community-based opioid substitution therapy and needle exchange programs should be implemented without delay.

摘要

目的

注射吸毒现在被认为是撒哈拉以南非洲艾滋病毒的一个重要危险因素。我们评估了尼日利亚注射吸毒者(IDU)中的艾滋病毒流行率和相关因素。

方法

采用基于应答者驱动抽样的横断面设计,于 2010 年在六个州进行。使用 RDS 分析工具计算加权 HIV 流行率和注射风险行为。按州分层,采用 logistic 回归确定 HIV 感染的相关因素。

结果

Lagos 的 IDU 人数为 197 人,Cross River 和 Oyo 州的 IDU 人数为 273 人。联邦首都直辖区(FCT)的 HIV 流行率最高,为 9.3%,卡杜纳为 5.8%,Oyo 为 5.1%,卡诺为 4.9%,CR 为 3.3%,拉各斯为 3.0%。尽管参与者中 90%以上为男性,但除 FCT 外,所有调查州的女性 HIV 流行率均较高(范围:CR 为 7.4%,卡诺为 37.7%)。Logistic 回归显示,女性在卡诺州[OR=33.2,95%CI:6.8-160.4]、Oyo 州[AOR=15.9,95%CI:3.69-68.51]、拉各斯州[OR=15.5,95%CI:2.41-99.5]和卡杜纳州[AOR=19.6,95%CI:4.4-87.6]中 HIV 阳性的可能性明显更高。在注射风险行为方面,仅接受性共用与 Oyo 和卡杜纳州的 HIV 相关[AOR=7.6,95%CI:1.2-48.7]和[AOR=0.2,95%CI:0.04-0.92]。

结论

尼日利亚各地 IDU 中 HIV 流行率和相关风险行为存在相当大的异质性。在六个州中的五个州,女性 IDU 的 HIV 流行率更高,这表明需要针对这一隐藏群体进行有针对性的干预。需要进一步研究以了解尼日利亚 IDU 中的 HIV 传播动态。应立即实施基于社区的阿片类物质替代疗法和针具交换方案。

相似文献

1
A profile on HIV prevalence and risk behaviors among injecting drug users in Nigeria: should we be alarmed?尼日利亚注射吸毒者中 HIV 流行率和风险行为简介:我们是否应该警惕?
Drug Alcohol Depend. 2013 Jan 1;127(1-3):65-71. doi: 10.1016/j.drugalcdep.2012.06.013. Epub 2012 Jul 8.
2
Correlates of injecting in an HIV incidence hotspot among substance users in Tijuana, Mexico.墨西哥蒂华纳市吸毒者中艾滋病毒高发区注射行为的相关因素
Int J Drug Policy. 2014 May;25(3):525-32. doi: 10.1016/j.drugpo.2013.12.005. Epub 2013 Dec 17.
3
Factors associated with HIV testing among male injecting drug users: findings from a cross-sectional behavioural and biological survey in Manipur and Nagaland, India.印度曼尼普尔邦和那加兰邦男性注射吸毒者中与艾滋病毒检测相关的因素:一项横断面行为和生物学调查的结果
Harm Reduct J. 2016 Jun 21;13(1):21. doi: 10.1186/s12954-016-0110-5.
4
HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.HIV 感染者和风险、预防、以及注射吸毒者的检测行为——全国 HIV 行为监测系统,2009 年,美国 20 个城市。
MMWR Surveill Summ. 2014 Jul 4;63(6):1-51.
5
A cross-sectional study on factors including HIV testing and counselling determining unsafe injecting practices among injecting drug users of Manipur.一项关于包括艾滋病毒检测与咨询在内的因素对曼尼普尔邦注射吸毒者不安全注射行为影响的横断面研究。
Indian J Public Health. 1995 Jul-Sep;39(3):86-92.
6
An analysis of respondent-driven sampling with injecting drug users in a high HIV prevalent state of India.印度艾滋病毒高发州的注射吸毒者中采用应答驱动抽样法分析。
Harm Reduct J. 2017 Jul 3;14(1):41. doi: 10.1186/s12954-017-0171-0.
7
Population-based prevalence of hepatitis B and C virus, HIV, syphilis, gonorrhoea and chlamydia in male injection drug users in Lagos, Nigeria.尼日利亚拉各斯男性注射吸毒者中基于人群的乙型和丙型肝炎病毒、艾滋病毒、梅毒、淋病和衣原体感染率
Int J STD AIDS. 2013 Aug;24(8):619-25. doi: 10.1177/0956462413477553. Epub 2013 Jul 19.
8
Background demographics and risk behaviors of injecting drug users in Karachi, Pakistan.巴基斯坦卡拉奇注射吸毒者的背景人口统计学特征及风险行为
Int J Infect Dis. 2006 Sep;10(5):364-71. doi: 10.1016/j.ijid.2005.07.010. Epub 2006 Jun 21.
9
Dual HIV risk: receptive syringe sharing and unprotected sex among HIV-negative injection drug users in New York City.双重 HIV 风险:纽约市 HIV 阴性注射吸毒者中接受性注射器共享和无保护性行为。
AIDS Behav. 2013 Sep;17(7):2501-9. doi: 10.1007/s10461-013-0496-y.
10
Rapid situational assessment of people who inject drugs (PWID) in Nairobi and coastal regions of Kenya: a respondent driven sampling survey.肯尼亚内罗毕和沿海地区注射吸毒者(PWID)的快速情境评估:一项基于受访者驱动抽样调查。
BMC Public Health. 2021 Aug 14;21(1):1549. doi: 10.1186/s12889-021-11373-9.

引用本文的文献

1
Mechanism of Viral Suppression among HIV Elite Controllers and Long-Term Nonprogressors in Nigeria and South Africa.尼日利亚和南非的 HIV 精英控制者和长期非进展者中病毒抑制的机制。
Viruses. 2022 Jun 10;14(6):1270. doi: 10.3390/v14061270.
2
HIV, hepatitis B virus, and hepatitis C virus co-infection among HIV positives in antiretroviral treatment program in selected hospitals in Addis Ababa: A retrospective cross-sectional study.在亚的斯亚贝巴选定医院的抗逆转录病毒治疗方案中的 HIV 阳性者中 HIV、乙型肝炎病毒和丙型肝炎病毒合并感染:一项回顾性横断面研究。
PLoS One. 2022 Apr 22;17(4):e0267230. doi: 10.1371/journal.pone.0267230. eCollection 2022.
3
Overview of the epidemiological conditions of HIV among key populations in Africa.
非洲重点人群中艾滋病毒流行状况概述。
J Int AIDS Soc. 2021 Jul;24 Suppl 3(Suppl 3):e25716. doi: 10.1002/jia2.25716.
4
The Opioid Epidemic in Africa And Its Impact.非洲的阿片类药物流行及其影响。
Curr Addict Rep. 2018 Dec;5(4):428-453. doi: 10.1007/s40429-018-0232-9. Epub 2018 Oct 30.
5
Prevalence and risk factors of HIV infection among people who inject drugs in Cambodia: findings from a national survey.柬埔寨注射吸毒人群中 HIV 感染的流行率和风险因素:一项全国性调查的结果。
Subst Abuse Treat Prev Policy. 2019 Oct 17;14(1):42. doi: 10.1186/s13011-019-0232-3.
6
Rising HIV prevalence among men who have sex with men in Nigeria: a trend analysis.尼日利亚男男性行为者中艾滋病毒感染率上升:趋势分析。
BMC Public Health. 2019 Sep 2;19(1):1201. doi: 10.1186/s12889-019-7540-4.
7
HIV-related knowledge, attitude and practices of healthy adults in Cross River State Nigeria: a population based-survey.尼日利亚克罗斯河州健康成年人的艾滋病相关知识、态度和行为:一项基于人群的调查。
Pan Afr Med J. 2017 Jul 4;27:170. doi: 10.11604/pamj.2017.27.170.12082. eCollection 2017.
8
A Systematic Review of Published Respondent-Driven Sampling Surveys Collecting Behavioral and Biologic Data.已发表的收集行为和生物学数据的应答驱动抽样调查的系统评价
AIDS Behav. 2016 Aug;20(8):1754-76. doi: 10.1007/s10461-016-1346-5.
9
Prevalence and behavioural risks for HIV and HCV infections in a population of drug users of Dakar, Senegal: the ANRS 12243 UDSEN study.塞内加尔达喀尔吸毒人群中艾滋病毒和丙型肝炎病毒感染的患病率及行为风险:法国国家艾滋病研究机构12243 UDSEN研究
J Int AIDS Soc. 2015 May 22;18(1):19888. doi: 10.7448/IAS.18.1.19888. eCollection 2015.
10
"Why should I take drugs for your infection?": outcomes of formative research on the use of HIV pre-exposure prophylaxis in Nigeria.“我为何要为你的感染服药?”:尼日利亚预防艾滋病病毒暴露前预防用药使用情况的形成性研究结果
BMC Public Health. 2015 Apr 10;15:349. doi: 10.1186/s12889-015-1690-9.